Download App
Current Complaints | Help Center| Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Surya Pharmaceutical Ltd (SURYAPHARM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532516 NSE: SURYAPHARM Pharmaceuticals & Drugs | Small Cap | Surya Pharmaceutical Share Price

BSE Share Price
Not Listed

Surya Pharmaceutical Ltd (SURYAPHARM)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 532516 NSE: SURYAPHARM Pharmaceuticals & Drugs | Small Cap | Surya Pharmaceutical Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹3 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-15.7
TTM Sales
₹90.4 Cr.
Book Value per Share
₹-4.2
P/E Ratio
0.00
Industry PE
53.6
Price to Book (P/B)
-0.04
Price to Sales (P/S)
0.04
EV/EBITDA
-11.92
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
-451.80%
Return on Capital Employed (ROCE)
-12.70%
Return on Assets (ROA)
-16.34%
Operating Profit Margin
-183.3%
Net Profit Margin
-367.83%
Gross Profit Margin
-425.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-96.28%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
0.96%
Pledged shares (%) of Promoter's holding (%)
26.18%
Reserves
₹-106 Cr.
Equity
₹20.3 Cr.
Face Value
₹1
All Time Low / High
₹0.15 / 35.59

Surya Pharmaceutical stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation ⓘ

Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13TTM
ROCE % ⓘ19.1%20.4%21.7%16.2%19.8%17.2%17.6%16.1%-10.8%-12.7%-

Growth Parameters ⓘ
Sales ⓘ1621692392834877231,1341,6001,62360.33
Sales YoY Gr.-4.3%41.2%18.8%71.7%48.6%56.9%41.1%1.4%-96.3%-
Adj EPS ⓘ0.60.81.91.62.945.15.2-12-13.712.8
YoY Gr.-38.6%143%-14.6%75.6%40.3%27%0.8%-332.1%NA-
BVPS (₹) ⓘ5.36.18.19.512.315.920.826.612.2-2.7-41
Adj Net
Profit ⓘ		68.421.323.741.758.574.299.7-243-278259
Cash Flow from Ops. ⓘ2.42.524.510.567.8-8.116568.9386166-
Debt/CF from Ops. ⓘ2126.6618.64.7-61.84.320.94.612.1-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘ-10.4%-34.1%-62.4%-96.3%
Adj EPS ⓘ-242.4%-236.6%-238.7%NA
BVPSⓘ-192.7%-173.7%-150.5%-122%
Share Price - - - -

Key Financial Parameters ⓘ

Mar'04Mar'05Mar'06Mar'07Mar'08Mar'09Mar'10Mar'11Mar'12Mar'13TTM
Return on
Equity % ⓘ		12.813.325.820.226.328.627.824.2-63.4-287.4-58.4
Op. Profit
Mgn % ⓘ		1417.719.718.317.816.614.416.4-8.8-257.6-1124.1
Net Profit
Mgn % ⓘ		3.758.98.48.68.16.56.2-15-4609952.8
Debt to
Equity ⓘ		0.911.61.41.82.22.42.87.1-37-
Working Cap
Days ⓘ		1802181982382272512482713036,5441,657
Cash Conv.
Cycle ⓘ		741081101521321231261962515,318-25,923

Valuation of Surya Pharmaceutical - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *97.2897.2897.2897.2896.7495.7878.8771.6726.1826.18
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'10Mar'11Mar'12Mar'13
Sales1,142.281,657.691,749.2190.44
Operating Expenses ⓘ + 981.351,402.971,962.32273.11
Manufacturing Costs26.9347.8646.367.67
Material Costs892.771,274.061,739.03200.49
Employee Cost 24.3048.1457.4713.93
Other Costs ⓘ 37.3532.91119.4651.02
Operating Profit ⓘ 160.93254.72-213.11-182.67
Operating Profit Margin (%) 14.1%15.4%-12.2%-202.0%
Other Income ⓘ + 10.574.896.060.97
Exceptional Items ⓘ 000-17.93
Interest ⓘ 62.53108.71186.59221.61
Depreciation ⓘ 20.8328.1139.3568.35
Profit Before Tax ⓘ 88.14122.79-432.98-489.58
Tax ⓘ 13.6930-128.20-156.90
Profit After Tax 74.4692.79-304.79-332.68
PAT Margin (%) 6.5%5.6%-17.4%-367.0%
Adjusted EPS (₹)4.74.2-12.2-12.8
Dividend Payout Ratio (%)3.20%3.60%0%0%
PARTICULARSMar'10Mar'11Mar'12Mar'13

Equity and Liabilities

Shareholders Fund + 301.88510.41228-80.73
Share Capital ⓘ 15.7222.0324.8124.81
Reserves ⓘ 286.17488.38203.19-105.53
Debt +718.971,405.801,786.372,047.32
Long Term Debt718.97281.42310.67384.09
Short Term Debt01,124.381,475.691,663.23
Minority Interest0.953.34-1.42-15.52
Trade Payables265.5186.4677.4633.73
Others Liabilities ⓘ 118.46223.9587.78-90.71
Total Liabilities ⓘ 1,405.782,229.962,178.191,894.08

Fixed Assets

Net Fixed Assets ⓘ +237.61434.27790.75726.74
Gross Block322.86547.87943.61947.95
Accumulated Depreciation85.25113.61152.86221.21
CWIP ⓘ 199.75244.5118.2418.85
Investments ⓘ 0.218.7359.0654.74
Inventories662.861,061.17831.83639.02
Trade Receivables155.23304.22250.36225.82
Cash Equivalents 19.3416.0915.998.13
Others Assets ⓘ 130.78160.98211.95220.77
Total Assets ⓘ 1,405.782,229.962,178.191,894.08
PARTICULARSMar'10Mar'11Mar'12Mar'13
Cash Flow From Operating Activity ⓘ + 162.7772.10365.68133.21
PBT ⓘ 88.14122.79-432.98-332.68
Adjustment ⓘ 74.13128.35213.39288.91
Changes in Working Capital ⓘ 8.56-162.9604.63303.23
Tax Paid ⓘ -8.06-16.14-19.36-144.19
Cash Flow From Investing Activity ⓘ + -148.30-270.23-179.91-7.95
Capex -156.92-261.85-130.29-9.02
Net Investments -0.01-8.51-50.340.20
Others ⓘ 8.640.140.720.86
Cash Flow From Financing Activity ⓘ + -3.79194.88-185.87-133.12
Net Proceeds from Shares ⓘ 0.9610.172.780
Net Proceeds from Borrowing ⓘ 59.51172.72-18.0273.41
Interest Paid ⓘ -62.53-98.52-173.24-217.86
Dividend Paid ⓘ -1.74-2.17-0.660
Others ⓘ 0112.683.2611.33
Net Cash Flow ⓘ 10.69-3.25-0.10-7.86
PARTICULARSMar'10Mar'11Mar'12Mar'13
Ratios
ROE (%)24.8522.91-82.55N/A
ROCE (%)14.7415.35-11.96N/A
Asset Turnover Ratio0.830.930.810.05
PAT to CFO Conversion(x)2.190.78N/AN/A
Working Capital Days
Receivable Days48.6049.5056.70917.30
Inventory Days207.60185.70193.602,833.50
Payable Days108.6050.4017.20101.20

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Surya Pharmaceutical Ltd FAQs

The current trading price of Surya Pharmaceutical on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Surya Pharmaceutical stood at ₹3.24 Cr

The latest P/E ratio of Surya Pharmaceutical as of 31-Dec-1969 is 0.01.

The latest P/B ratio of Surya Pharmaceutical as of 31-Dec-1969 is 0.00.

The 52-week high of Surya Pharmaceutical is ₹0.16 and the 52-week low is ₹0.16.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Surya Pharmaceutical is ₹2.60 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Surya Pharmaceutical Ltd

Surya Pharmaceutical incorporated in 1992, is engaged in manufacturing of active pharmaceutical ingredients (API's), finished drug formulations (FDF's), fine intermediates, herbal products, and mint/menthol derivatives. The company has client based in over 90 countries across the globe.

The company has received ISO 9001-2000 certifications for its quality management. The company is listed on the Bombay Stock Exchange and the National Stock Exchange. The company has employee strength of more than 2000 people. Company offices located at Shanghai, Singapore, Europe and the United States of America (USA).

Company has production capacity of 600 million of capsules and tablets each per annum.

Products

Intermediates- Under this company manufactures Cefuroxime Acid, Cefaclor and many more.

API-Company has annual capacity of 2500MT of API under which it produces Ampicillin Trihydrat, Cloxacillin Sodium, Flucloxacillin Sodium, Cefprozil, Cefpodoxime Proxetil, Bacampicillin Hydrochloride, Oxacillin Sodium, Cefuroxime Axetil and many more.

Menthol- Under this company manufactures Menthol Powder, Menthol Crystals, Menthol Flakes, Essential Oil, Basil Oil, Dementholised Peppermint Oil, Natural Mint Terpenes, CIS-3-Hexenol, Menthones, Mentha Piperita Oil, Spearmint Oil and Menthyl Lactate. Company has annual production capacity of 4500 MT of Menthol Powder, 3600 MT of Menthol Crystals and 2800 MT of Dementholised Pepermint oil.

Herbal Products- Company manufactures products such as Quinine Sulphate, Quinine Hydrochloride, Colchicine, Thiocolchicoside, Raubasine, 5-HTP and 10-DAB III.

Company also conduct contract manufacturing for various companies.

Recent DevelopmentSurya Pharmaceutical plans to establish 500 healthcare and pharma retail stores in the next three years at an investment of Rs.250 crore. By March 2010, company would open 100 stores in the NCR (national capital region).

You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now